Cargando…

Vascular Endothelial Growth Factor plus Epidermal Growth Factor Receptor Dual Targeted Therapy in Metastatic Colorectal Cancer: Synergy or Antagonism?

There has been an intensive effort to develop novel therapies for the treatment of metastatic colorectal cancer (mCRC). The anti-epidermal growth factor receptor (EGFR) antibodies panitumumab and cetuximab and the anti-vascular endothelial growth factor (VEGF) antibody bevacizumab have demonstrated...

Descripción completa

Detalles Bibliográficos
Autor principal:	Marshall, John L.
Formato:	Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2009
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2792961/ https://www.ncbi.nlm.nih.gov/pubmed/20016807 http://dx.doi.org/10.1155/2009/937305

Ejemplares similares

Molecular Targeting of Epidermal Growth Factor Receptor (EGFR) and Vascular Endothelial Growth Factor Receptor (VEGFR)
por: Kaufman, Nichole E. M., et al.
Publicado: (2021)

Diagnostic Values of Vascular Endothelial Growth Factor and Epidermal Growth Factor Receptor for Benign and Malignant Hydrothorax
por: Gu, Yan, et al.
Publicado: (2015)

Epidermal growth factor receptor mutation enhances expression of vascular endothelial growth factor in lung cancer
por: Hung, Ming-Szu, et al.
Publicado: (2016)

Inhibited growth of colon cancer carcinomatosis by antibodies to vascular endothelial and epidermal growth factor receptors
por: Shaheen, R M, et al.
Publicado: (2001)

Epidermal growth factor receptor immunohistochemistry: new opportunities in metastatic colorectal cancer
por: Hutchinson, Ryan A, et al.
Publicado: (2015)

Epidermal growth factor receptors in vascular endothelial cells contribute to functional hyperemia in the brain
por: Ferris, Hannah R., et al.
Publicado: (2023)

Epidermal Growth Factor Receptors in Vascular Endothelial Cells Contribute to Functional Hyperemia in the Brain
por: Ferris, Hannah R., et al.
Publicado: (2023)

Expression of Vascular Endothelial Growth Factor and Epidermal Growth Factor Receptor in Pancreatic Ductal Adenocarcinomas, Neuroendocrine Tumours and Chronic Pancreatitis
por: Angelescu, Radu, et al.
Publicado: (2013)

Diversity in tumor territory of meningioma: Protein expression in vascular endothelial growth factor and epidermal growth factor
por: Mehdipour, Parvin, et al.
Publicado: (2019)

Effects of vascular endothelial growth factor and epidermal growth factor on biological properties of gastric cancer cells
por: Li, Chunfeng, et al.
Publicado: (2019)

Predicting response to vascular endothelial growth factor inhibitor and chemotherapy in metastatic colorectal cancer
por: Martin, Petra, et al.
Publicado: (2014)

Efficacy and safety of anti-epidermal growth factor receptor therapy compared with anti-vascular endothelial growth factor therapy for metastatic colorectal cancer in first-line and second-line therapies: a meta-analysis
por: Wang, Hongchi, et al.
Publicado: (2016)

Oncogenic fingerprint of epidermal growth factor receptor pathway and emerging epidermal growth factor receptor blockade resistance in colorectal cancer
por: Sobani, Zain A, et al.
Publicado: (2016)

Anti-epidermal or anti-vascular endothelial growth factor as first-line metastatic colorectal cancer in modified Glasgow prognostic score 2' patients
por: Dréanic, Johann, et al.
Publicado: (2015)

Expression of Vascular Endothelial Growth Factor (VEGF) and Epidermal Growth Factor Receptor (EGFR) in Patients With Serous Ovarian Carcinoma and Their Clinical Significance
por: Ranjbar, Reza, et al.
Publicado: (2015)

Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing
Publicado: (1992)

Patritumab plus trastuzumab and paclitaxel in human epidermal growth factor receptor 2‐overexpressing metastatic breast cancer
por: Mukai, Hirofumi, et al.
Publicado: (2016)

Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma by Targeting the Epidermal Growth Factor Receptor Combined with Gemcitabine Plus Platinum
por: Chen, Chen, et al.
Publicado: (2020)

Induction of neuropilin-1 and vascular endothelial growth factor by epidermal growth factor in human gastric cancer cells
por: Akagi, M, et al.
Publicado: (2003)

Epidermal Growth Factor Receptor Mutations in Colorectal Cancer Patients
por: Oh, Bo-Young, et al.
Publicado: (2011)

Enhanced expression of vascular endothelial growth factor in metastatic melanoma.
por: Salven, P., et al.
Publicado: (1997)

In vivo effect of an luteinizing hormone-releasing hormone analog on vascular endothelial growth factor and epidermal growth factor receptor expression in mammary tumors
por: Flores, Ana Isabel, et al.
Publicado: (2009)

Biomarkers Predicting Clinical Outcome of Epidermal Growth Factor Receptor–Targeted Therapy in Metastatic Colorectal Cancer
por: Siena, Salvatore, et al.
Publicado: (2009)

Natural History of Human Epidermal Growth Factor Receptor 2–Amplified and Human Epidermal Growth Factor Receptor 2 Wild-Type Refractory Metastatic Colorectal Cancer in US Clinical Practice
por: Schröder, Carsten, et al.
Publicado: (2022)

Vascular endothelial growth factor‐C in activating vascular endothelial growth factor receptor‐3 and chemokine receptor‐4 in melanoma adhesion
por: Hlophe, Yvette N., et al.
Publicado: (2022)

Endothelial epidermal growth factor receptor is of minor importance for vascular and renal function and obesity-induced dysfunction in mice
por: Schreier, Barbara, et al.
Publicado: (2021)

Targeted Antagonism of Vascular Endothelial Growth Factor Reduces Mortality of Mice with Acute Respiratory Distress Syndrome
por: Zhang, Zhao, et al.
Publicado: (2020)

Vascular Endothelial Growth Factor Receptor-1 Expression in Breast Cancer and Its Correlation to Vascular Endothelial Growth Factor A
por: Srabovic, Nahida, et al.
Publicado: (2013)

Expression of vascular endothelial growth factor-C and vascular endothelial growth factor receptor-3 in esophageal squamous cell carcinoma
por: OMOTO, ITARU, et al.
Publicado: (2014)

Galectin-3 Enhances Vascular Endothelial Growth Factor-A Receptor 2 Activity in the Presence of Vascular Endothelial Growth Factor
por: Cano, Issahy, et al.
Publicado: (2021)

Interleukin-4 receptor and epidermal growth factor receptor expression in colorectal cancer.
por: Kaklamanis, L., et al.
Publicado: (1992)

Salivary Vascular Endothelial Growth Factor and Epidermal Growth Factor Levels in Patients with Recurrent Aphthous Stomatitis: a Meta-Analysis
por: Motahari, Paria, et al.
Publicado: (2023)

Transforming growth factor alpha and epidermal growth factor levels in bladder cancer and their relationship to epidermal growth factor receptor.
por: Mellon, J. K., et al.
Publicado: (1996)

Expression and localization of epidermal growth factor, transforming growth factor-α and epidermal growth factor receptor in the canine testis
por: TAMADA, Hiromichi, et al.
Publicado: (2015)

Targeting Epidermal Growth Factor Receptor (EGFR) in Pediatric Colorectal Cancer
por: De Pasquale, Maria Debora, et al.
Publicado: (2020)

The Role of Vascular Endothelial Growth Factor in Metastatic Prostate Cancer to the Skeleton
por: Roberts, Emma, et al.
Publicado: (2013)

DNA methylation status as a biomarker of anti‐epidermal growth factor receptor treatment for metastatic colorectal cancer
por: Ouchi, Kota, et al.
Publicado: (2015)

Skin inflammatory response and efficacy of anti-epidermal growth factor receptor therapy in metastatic colorectal cancer (CUTACETUX)
por: Tougeron, David, et al.
Publicado: (2020)

Effect of human epidermal growth factor receptor 2 overexpression in metastatic colorectal cancer on standard chemotherapy outcomes
por: Jang, Jae Yeon, et al.
Publicado: (2023)

Targeting the epidermal growth factor receptor
por: El-Rayes, B F, et al.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_5as4caus7vjom5fo8b8hpp0ro7